Macrogenics Inc (MGNX)
15.70
-0.53
(-3.27%)
USD |
NASDAQ |
Apr 24, 16:00
15.72
+0.02
(+0.13%)
After-Hours: 20:00
Macrogenics Gross Profit Margin (Quarterly): 98.22% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 98.22% |
| September 30, 2023 | 67.69% |
| June 30, 2023 | 91.04% |
| March 31, 2023 | 85.45% |
| December 31, 2022 | 97.48% |
| September 30, 2022 | 92.47% |
| Date | Value |
|---|---|
| June 30, 2022 | 90.76% |
| March 31, 2022 | 99.55% |
| December 31, 2021 | 92.33% |
| September 30, 2021 | 89.37% |
| June 30, 2021 | 99.93% |
| March 31, 2021 | 99.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.69%
Minimum
Sep 2023
99.93%
Maximum
Jun 2021
92.02%
Average
92.40%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Allurion Technologies Inc | 78.08% |
| United Therapeutics Corp | 88.45% |
| MEI Pharma Inc | -- |
| Marinus Pharmaceuticals Inc | 87.66% |
| Voyager Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -5.89% |
| Return on Assets | -2.89% |
| Return on Invested Capital | -5.89% |
| Profit Margin (Quarterly) | -502.7% |
| Operating Margin (Quarterly) | -538.6% |
| Return on Net Operating Assets | -11.50% |